MOTS-c is a mitochondrial-derived peptide studied in metabolic signaling and skeletal-muscle adaptation, with experimental interventions supported mainly by cell and animal evidence.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Mitochondrial-derived signaling peptide
MOTS-c is a 16-amino-acid peptide associated with a short open reading frame in the mitochondrial 12S ribosomal RNA region. Its discovery expanded interest in mitochondria as sources of signaling molecules as well as sites of energy metabolism.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
Early experiments linked MOTS-c to altered folate and purine metabolism and activation of the energy-sensing enzyme AMPK. Later work identified the protein kinase CK2 as a direct binding partner, with different effects in muscle and fat. These findings suggest context-dependent signaling rather than a single universal metabolic switch.
The discovery study examined cellular metabolism and mice exposed to aging or a high-fat diet. Reported changes in insulin sensitivity and weight-related outcomes support further investigation of mitochondrial signaling, but do not establish equivalent effects in human recipients. [1]
A subsequent study reported improved physical performance after experimental MOTS-c administration in mice. Its human component measured the body's own peptide response to exercise. Observing an endogenous response differs fundamentally from testing an administered peptide in people. [2]
Experiments using binding assays, cells and mice linked CK2 activity to muscle glucose uptake and protection against atrophy. Associations involving a naturally occurring human MOTS-c variant added biological context, without providing a clinical intervention trial. [3]
Study topics describe the cited models, not established benefits of this catalog material.
The selected literature combines mechanistic experiments, mouse outcomes and human observations. Human exercise measurements and genetic associations can help form hypotheses, but neither establishes that administering MOTS-c improves performance, treats metabolic disease or extends healthy lifespan.
Species, tissue and experimental-stress differences complicate translation. Biomarker changes should be separated from durable functional outcomes, and findings from related mitochondrial peptides should not be substituted for MOTS-c data. These publications do not validate any WYZ material or demonstrate equivalence to the preparations used by the investigators.
Primary studies and clearly identified supporting sources. Each link opens the original record.
Foundational sequence, metabolic-pathway and mouse experiments.
Mouse interventions plus endogenous exercise responses in humans.
CK2 binding and tissue-specific effects; human variant associations are noninterventional.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COAOther single compounds in the collection.
Metabolic Research
Retatrutide is a synthetic peptide studied for coordinated activation of three metabolic hormone receptors, with human research examining glucose regulation, appetite, body weight and liver fat.
Dermal Research
GHK-Cu is a copper complex of glycyl-histidyl-lysine studied for its effects on extracellular-matrix production and remodeling in experimental tissue-repair systems.
Secretagogue Research
Tesamorelin is a stabilized GHRH analogue studied for changes in visceral and liver fat, principally in people with HIV-associated abdominal adiposity.
